Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia

It was recently recognized that some chronic myeloid leukemia patients with a complete molecular response could sustain that response after discontinuation of imatinib. To characterize the clinical outcomes and profiles of chronic phase chronic myeloid leukemia patients who could discontinue imatini...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Takahashi, Naoto, Kyo, Taiichi, Maeda, Yasuhiro, Sugihara, Takashi, Usuki, Kensuke, Kawaguchi, Tatsuya, Usui, Noriko, Okamoto, Shinichiro, Ohe, Yokiko, Ohtake, Shigeki, Kitamura, Kunio, Yamamoto, Masahide, Teshima, Hirofumi, Motoji, Toshiko, Tamaki, Toshiharu, Sawada, Kenichi, Ohyashiki, Kazuma
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2012
Matèries:
Original Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3366657/
https://ncbi.nlm.nih.gov/pubmed/22180435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.056853
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars